ArticleEpilepsy & behavior reports2026
A potential therapeutic role of unilateral anterior thalamic deep brain stimulation in epileptic spasms: A case report.
Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an established palliative therapy for drug-resistant focal epilepsy; however, its efficacy for epileptic spasms (ES) and the clinical utility of unilateral stimulation remain unclear. To address these issues, we report a case of drug-resistant focal epilepsy with ES treated with unilateral ANT-DBS. Case: An 18-year-old right-handed male with focal cortical dysplasia type I had long-standing drug-resistant epilepsy. Despite multiple resective and palliative surgeries-including right frontal disconnection, corpus callosotomy, right anterior temporal lobectomy, and vagus nerve stimulation-daily ES, weekly focal impaired consciousness seizures (FIC), and monthly focal-to-bilateral tonic-clonic seizures (FBTC) persisted. Presurgical evaluation suggested an epileptic focus in the left temporal lobe for FIC/FBTC. ANT-DBS was planned for seizure alleviation. Lead implantation on the right side was considered unfavorable because of marked postsurgical atrophy. Therefore, unilateral ANT-DBS lead implantation on the left side was performed. Results: After implantation, ES frequency transiently decreased (median 0.46 seizures/day) but later increased during follow-up. Stimulation was initiated on postoperative day 22. After the stimulation amplitude reached ≥2.0 mA (postoperative day 92), the median spasm frequency decreased again to 0.31/day, lower than the preoperative baseline of 0.75/day (58.1% reduction; Significance: Unilateral ANT-DBS was associated with a clinically meaningful reduction in ES in this highly refractory case, suggesting a potential therapeutic role even when bilateral implantation is not feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.